{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:24:09Z","timestamp":1791429849961,"version":"4.3.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Grants of Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["21K15586"],"award-info":[{"award-number":["21K15586"]}]},{"name":"the Grants of Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["18K08558"],"award-info":[{"award-number":["18K08558"]}]},{"name":"grants from the National Center for Child Health and Development","award":["2021C-40"],"award-info":[{"award-number":["2021C-40"]}]},{"name":"grants from the National Center for Child Health and Development","award":["29-09"],"award-info":[{"award-number":["29-09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00262-022-03276-4","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T06:05:39Z","timestamp":1662098739000},"page":"719-731","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["PD-L1 antibody enhanced \u03b2-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model"],"prefix":"10.1007","volume":"72","author":[{"given":"Xin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisato","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"issue":"10","key":"3276_CR1","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1172\/JCI45862","volume":"121","author":"T Lu","year":"2011","unstructured":"Lu T, Ramakrishnan R, Altiok S, Youn JI, Cheng P, Celis E, Pisarev V, Sherman S, Sporn MB, Gabrilovich D (2011) Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J Clin Invest 121(10):4015\u20134029. https:\/\/doi.org\/10.1172\/JCI45862","journal-title":"J Clin Invest"},{"issue":"2","key":"3276_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.08.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC, Ferris RL, Delgoffe GM (2016) The Tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45(2):374\u2013388. https:\/\/doi.org\/10.1016\/j.immuni.2016.08.009","journal-title":"Immunity"},{"issue":"1","key":"3276_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13045-021-01156-5","volume":"14","author":"JA Park","year":"2001","unstructured":"Park JA, Wang L, Cheung NV (2001) Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response. J Hematol Oncol 14(1):142. https:\/\/doi.org\/10.1186\/s13045-021-01156-5","journal-title":"J Hematol Oncol"},{"issue":"4","key":"3276_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/intimm\/dxy079","volume":"31","author":"T Uehara","year":"2019","unstructured":"Uehara T, Eikawa S, Nishida M, Kunisada Y, Yoshida A, Fujiwara T, Kunisada T, Ozaki T, Udono H (2019) Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects. Int Immunol 31(4):187\u2013198. https:\/\/doi.org\/10.1093\/intimm\/dxy079","journal-title":"Int Immunol"},{"issue":"3","key":"3276_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","volume":"183","author":"L Kalafati","year":"2020","unstructured":"Kalafati L, Kourtzelis I, Schulte-Schrepping J, Li X, Hatzioannou A, Grinenko T, Hagag E, Sinha A, Has C, Dietz S et al (2020) Innate immune training of granulopoiesis promotes anti-tumor activity. Cell 183(3):771-785 e12. https:\/\/doi.org\/10.1016\/j.cell.2020.09.058","journal-title":"Cell"},{"issue":"7","key":"3276_CR6","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1182\/blood-2009-08-237412","volume":"115","author":"SJ Priceman","year":"2010","unstructured":"Priceman SJ, Sung JL, Shaposhnik Z, Burton JB, Torres-Collado AX, Moughon DL, Johnson M, Lusis AJ, Cohen DA, Iruela-Arispe ML et al (2010) Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood 115(7):1461\u20131471. https:\/\/doi.org\/10.1182\/blood-2009-08-237412","journal-title":"Blood"},{"key":"3276_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1756-8722-2-25","volume":"2","author":"GC Chan","year":"2009","unstructured":"Chan GC, Chan WK, Sze DM (2009) The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol 2:25. https:\/\/doi.org\/10.1186\/1756-8722-2-25","journal-title":"J Hematol Oncol"},{"issue":"7","key":"3276_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/molecules24071251","volume":"24","author":"V Vetvicka","year":"2019","unstructured":"Vetvicka V, Vannucci L, Sima P, Richter J (2019) Beta Glucan: Supplement or Drug? From laboratory to clinical trials. Molecules 24(7):1251. https:\/\/doi.org\/10.3390\/molecules24071251","journal-title":"Molecules"},{"issue":"4","key":"3276_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/jof6040356","volume":"6","author":"EJ Murphy","year":"2020","unstructured":"Murphy EJ, Rezoagli E, Major I, Rowan NJ, Laffey JG (2020) Beta-glucan metabolic and immunomodulatory properties and potential for clinical application. J Fungi (Basel) 6(4):356. https:\/\/doi.org\/10.3390\/jof6040356","journal-title":"J Fungi (Basel)"},{"issue":"5","key":"3276_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nm.4314","volume":"23","author":"D Daley","year":"2017","unstructured":"Daley D, Mani VR, Mohan N, Akkad N, Ochi A, Heindel DW, Lee KB, Zambirinis CP, Pandian GSB, Savadkar S et al (2017) Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med 23(5):556\u2013567. https:\/\/doi.org\/10.1038\/nm.4314","journal-title":"Nat Med"},{"issue":"6","key":"3276_CR11","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s12257-013-0516-9","volume":"18","author":"N Moriya","year":"2014","unstructured":"Moriya N, Moriya Y, Nomura H, Kusano K, Asada Y, Uchiyama H, Park EY, Okabe M (2014) Improved \u03b2-glucan yield using an Aureobasidium pullulans M-2 mutant strain in a 200-L pilot scale fermentor targeting industrial mass production. Biotechnol Bioprocess Eng 18(6):1083\u20131089","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"7","key":"3276_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041399","volume":"7","author":"D Muramatsu","year":"2012","unstructured":"Muramatsu D, Iwai A, Aoki S, Uchiyama H, Kawata K, Nakayama Y, Nikawa Y, Kusano K, Okabe M, Miyazaki T (2012) beta-Glucan derived from Aureobasidium pullulans is effective for the prevention of influenza in mice. PLoS ONE 7(7):e41399. https:\/\/doi.org\/10.1371\/journal.pone.0041399","journal-title":"PLoS ONE"},{"issue":"Pt A","key":"3276_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108265","volume":"101","author":"Y Shui","year":"2021","unstructured":"Shui Y, Hu X, Hirano H, Kusano K, Tsukamoto H, Li M, Hasumi K, Guo WZ, Li XK (2021) Beta-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells. Int Immunopharmacol 101(Pt A):108265. https:\/\/doi.org\/10.1016\/j.intimp.2021.108265","journal-title":"Int Immunopharmacol"},{"issue":"15","key":"3276_CR14","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.3390\/ijms20153618","volume":"20","author":"A Geller","year":"2019","unstructured":"Geller A, Shrestha R, Yan J (2019) Yeast-derived beta-glucan in cancer: novel uses of a traditional therapeutic. Int J Mol Sci 20(15):3618. https:\/\/doi.org\/10.3390\/ijms20153618","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3276_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1084\/jem.20160801","volume":"214","author":"VR Juneja","year":"2017","unstructured":"Juneja VR, McGuire KA, Manguso RT, LaFleur MW, Collins N, Haining WN, Freeman GJ, Sharpe AH (2017) PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. J Exp Med 214(4):895\u2013904. https:\/\/doi.org\/10.1084\/jem.20160801","journal-title":"J Exp Med"},{"issue":"10","key":"3276_CR16","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC (2010) Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 207(10):2187\u20132194. https:\/\/doi.org\/10.1084\/jem.20100643","journal-title":"J Exp Med"},{"issue":"1","key":"3276_CR17","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","volume":"11","author":"Q Peng","year":"2020","unstructured":"Peng Q, Qiu X, Zhang Z, Zhang S, Zhang Y, Liang Y, Guo J, Peng H, Chen M, Fu YX et al (2020) PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade. Nat Commun 11(1):4835. https:\/\/doi.org\/10.1038\/s41467-020-18570-x","journal-title":"Nat Commun"},{"issue":"5","key":"3276_CR18","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3892\/or.2020.7767","volume":"44","author":"T Shan","year":"2020","unstructured":"Shan T, Chen S, Chen X, Wu T, Yang Y, Li S, Ma J, Zhao J, Lin W, Li W et al (2020) M2TAM subsets altered by lactic acid promote Tcell apoptosis through the PDL1\/PD1 pathway. Oncol Rep 44(5):1885\u20131894. https:\/\/doi.org\/10.3892\/or.2020.7767","journal-title":"Oncol Rep"},{"issue":"7655","key":"3276_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, Gupta R, Tsai JM, Sinha R, Corey D et al (2017) PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545(7655):495\u2013499. https:\/\/doi.org\/10.1038\/nature22396","journal-title":"Nature"},{"issue":"8","key":"3276_CR20","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1172\/JCI127726","volume":"129","author":"Y Wei","year":"2019","unstructured":"Wei Y, Zhao Q, Gao Z, Lao XM, Lin WM, Chen DP, Mu M, Huang CX, Liu ZY, Li B et al (2019) The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy. J Clin Invest 129(8):3347\u20133360. https:\/\/doi.org\/10.1172\/JCI127726","journal-title":"J Clin Invest"},{"issue":"2","key":"3276_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057114","volume":"8","author":"B Zhang","year":"2013","unstructured":"Zhang B, Wang Z, Wu L, Zhang M, Li W, Ding J, Zhu J, Wei H, Zhao K (2013) Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PLoS ONE 8(2):e57114. https:\/\/doi.org\/10.1371\/journal.pone.0057114","journal-title":"PLoS ONE"},{"key":"3276_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.588552","volume":"11","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Zhang H, Chen B, Liu X, Zhang S, Zong Z, Gao M (2020) PD-L1-mediated immunosuppression in glioblastoma is Associated with the infiltration and M2-polarization of tumor-associated macrophages. Front Immunol 11:588552. https:\/\/doi.org\/10.3389\/fimmu.2020.588552","journal-title":"Front Immunol"},{"issue":"5","key":"3276_CR23","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3892\/or.2015.3876","volume":"33","author":"H Tsukihara","year":"2015","unstructured":"Tsukihara H, Nakagawa F, Sakamoto K, Ishida K, Tanaka N, Okabe H, Uchida J, Matsuo K, Takechi T (2015) Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts. Oncol Rep 33(5):2135\u20132142. https:\/\/doi.org\/10.3892\/or.2015.3876","journal-title":"Oncol Rep"},{"issue":"2","key":"3276_CR24","first-page":"146","volume":"25","author":"JIN Z-j","year":"2004","unstructured":"Z-j JIN (2004) About the evaluationof drug combination. Acta Pharmacol Sin 25(2):146\u2013147","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"3276_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41419-020-02880-5","volume":"11","author":"K Wang","year":"2020","unstructured":"Wang K, Liu X, Liu Q, Ho IH, Wei X, Yin T, Zhan Y, Zhang W, Zhang W, Chen B et al (2020) Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells. Cell Death Dis 11(8):611. https:\/\/doi.org\/10.1038\/s41419-020-02880-5","journal-title":"Cell Death Dis"},{"key":"3276_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.actbio.2021.08.013","volume":"135","author":"N Shen","year":"2021","unstructured":"Shen N, Yang C, Zhang X, Tang Z, Chen X (2021) Cisplatin nanoparticles possess stronger anti-tumor synergy with PD1\/PD-L1 inhibitors than the parental drug. Acta Biomater 135:543\u2013555. https:\/\/doi.org\/10.1016\/j.actbio.2021.08.013","journal-title":"Acta Biomater"},{"issue":"4","key":"3276_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND (2013) How to calculate sample size in animal studies? J Pharmacol Pharmacother 4(4):303\u2013306. https:\/\/doi.org\/10.4103\/0976-500X.119726","journal-title":"J Pharmacol Pharmacother"},{"key":"3276_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H (2021) Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof 18:17. https:\/\/doi.org\/10.3352\/jeehp.2021.18.17","journal-title":"J Educ Eval Health Prof"},{"issue":"2","key":"3276_CR29","first-page":"175","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social. Behav Biomed Sci 39(2):175\u2013191","journal-title":"Behav Biomed Sci"},{"issue":"1","key":"3276_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1172\/JCI118777","volume":"98","author":"V Vetvicka","year":"1996","unstructured":"Vetvicka V, Thornton BP, Ross GD (1996) Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b\/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 98(1):50\u201361. https:\/\/doi.org\/10.1172\/JCI118777","journal-title":"J Clin Invest"},{"key":"3276_CR31","doi-asserted-by":"publisher","first-page":"e58065","DOI":"10.7554\/eLife.58065","volume":"9","author":"P Chitirala","year":"2020","unstructured":"Chitirala P, Chang HF, Martzloff P, Harenberg C, Ravichandran K, Abdulreda MH, Berggren PO, Krause E, Schirra C, Leinders-Zufall T, Benseler F, Brose N, Rettig J (2020) Studying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse. Elife 9:e58065. https:\/\/doi.org\/10.7554\/eLife.58065","journal-title":"Elife"},{"issue":"6","key":"3276_CR32","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.4049\/jimmunol.179.6.3812","volume":"179","author":"BZ Packard","year":"2007","unstructured":"Packard BZ, Telford WG, Komoriya A, Henkart PA (2007) Granzyme B activity in target cells detects attack by cytotoxic lymphocytes. J Immunol 179(6):3812\u20133820. https:\/\/doi.org\/10.4049\/jimmunol.179.6.3812","journal-title":"J Immunol"},{"key":"3276_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jim.2015.02.011","volume":"419","author":"E Wattrang","year":"2015","unstructured":"Wattrang E, Dalgaard TS, Norup LR, Kjaerup RB, Lunden A, Juul-Madsen HR (2015) CD107a as a marker of activation in chicken cytotoxic T cells. J Immunol Methods 419:35\u201347. https:\/\/doi.org\/10.1016\/j.jim.2015.02.011","journal-title":"J Immunol Methods"},{"issue":"3","key":"3276_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101033","volume":"297","author":"N Anikeeva","year":"2021","unstructured":"Anikeeva N, Panteleev S, Mazzanti NW, Terai M, Sato T, Sykulev Y (2021) Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs. J Biol Chem 297(3):101033. https:\/\/doi.org\/10.1016\/j.jbc.2021.101033","journal-title":"J Biol Chem"},{"issue":"1","key":"3276_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/1547691X.2018.1486342","volume":"15","author":"B Frank","year":"2018","unstructured":"Frank B, Wei Y-L, Kim K-H, Guerrero A, Lebrec H, Balazs M, Wang X (2018) Development of a BiTE\u00ae-mediated CD8+ cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaque. J Immunotoxicol 15(1):119\u2013125. https:\/\/doi.org\/10.1080\/1547691X.2018.1486342","journal-title":"J Immunotoxicol"},{"issue":"5","key":"3276_CR36","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.4049\/jimmunol.180.5.3132","volume":"180","author":"AA Lugade","year":"2008","unstructured":"Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, Lord EM (2008) Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. J Immunol 180(5):3132\u20133139. https:\/\/doi.org\/10.4049\/jimmunol.180.5.3132","journal-title":"J Immunol"},{"issue":"6","key":"3276_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1163462","volume":"5","author":"T Jiang","year":"2016","unstructured":"Jiang T, Zhou C, Ren S (2016) Role of IL-2 in cancer immunotherapy. Oncoimmunology 5(6):e1163462. https:\/\/doi.org\/10.1080\/2162402X.2016.1163462","journal-title":"Oncoimmunology"},{"issue":"1","key":"3276_CR38","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1038\/s41467-018-05032-8","volume":"9","author":"SN Gettinger","year":"2018","unstructured":"Gettinger SN, Choi J, Mani N, Sanmamed MF, Datar I, Sowell R, Du VY, Kaftan E, Goldberg S, Dong W et al (2018) A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers. Nat Commun 9(1):3196. https:\/\/doi.org\/10.1038\/s41467-018-05032-8","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"3276_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jim.2010.08.007","volume":"362","author":"A Soares","year":"2010","unstructured":"Soares A, Govender L, Hughes J, Mavakla W, de Kock M, Barnard C, Pienaar B, Janse van Rensburg E, Jacobs G, Khomba G et al (2010) Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods 362(1\u20132):43\u201350. https:\/\/doi.org\/10.1016\/j.jim.2010.08.007","journal-title":"J Immunol Methods"},{"issue":"1","key":"3276_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2326-6066.CIR-14-0098","volume":"3","author":"H Matsushita","year":"2015","unstructured":"Matsushita H, Hosoi A, Ueha S, Abe J, Fujieda N, Tomura M, Maekawa R, Matsushima K, Ohara O, Kakimi K (2015) Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFNgamma-dependent cell-cycle arrest. Cancer Immunol Res 3(1):26\u201336. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0098","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"3276_CR41","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1073\/pnas.1417636112","volume":"112","author":"S Eikawa","year":"2015","unstructured":"Eikawa S, Nishida M, Mizukami S, Yamazaki C, Nakayama E, Udono H (2015) Immune-mediated antitumor effect by type 2 diabetes drug, metformin. Proc Natl Acad Sci U S A 112(6):1809\u20131814. https:\/\/doi.org\/10.1073\/pnas.1417636112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3276_CR42","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3389\/fimmu.2018.01977","volume":"9","author":"RM Awad","year":"2018","unstructured":"Awad RM, De Vlaeminck Y, Maebe J, Goyvaerts C, Breckpot K (2018) Turn back the TIMe: targeting tumor infiltrating myeloid cells to revert cancer progression. Front Immunol 9:1977. https:\/\/doi.org\/10.3389\/fimmu.2018.01977","journal-title":"Front Immunol"},{"issue":"3","key":"3276_CR43","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nnano.2016.168","volume":"17","author":"J Van den Bossche","year":"2016","unstructured":"Van den Bossche J, Baardman J, Otto NA, van der Velden S, Neele AE, van den Berg SM, Luque-Martin R, Chen HJ, Boshuizen MC, Ahmed M et al (2016) Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep 17(3):684\u2013696. https:\/\/doi.org\/10.1038\/nnano.2016.168","journal-title":"Cell Rep"},{"issue":"11","key":"3276_CR44","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nnano.2016.168","volume":"11","author":"S Zanganeh","year":"2016","unstructured":"Zanganeh S, Hutter G, Spitler R, Lenkov O, Mahmoudi M, Shaw A, Pajarinen JS, Nejadnik H, Goodman S, Moseley M et al (2016) Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol 11(11):986\u2013994","journal-title":"Nat Nanotechnol"},{"key":"3276_CR45","doi-asserted-by":"publisher","first-page":"6058147","DOI":"10.1155\/2016\/6058147","volume":"2016","author":"J Kim","year":"2016","unstructured":"Kim J, Bae JS (2016) Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm 2016:6058147. https:\/\/doi.org\/10.1155\/2016\/6058147","journal-title":"Mediators Inflamm"},{"issue":"9","key":"3276_CR46","doi-asserted-by":"publisher","DOI":"10.4161\/2162402X.2014.988473","volume":"4","author":"D Di Mitri","year":"2015","unstructured":"Di Mitri D, Toso A, Alimonti A (2015) Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumors. Oncoimmunology 4(9):e988473. https:\/\/doi.org\/10.4161\/2162402X.2014.988473","journal-title":"Oncoimmunology"},{"key":"3276_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ebiom.2016.02.024","volume":"6","author":"RB Holmgaard","year":"2016","unstructured":"Holmgaard RB, Zamarin D, Lesokhin A, Merghoub T, Wolchok JD (2016) Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors. EBioMedicine 6:50\u201358","journal-title":"EBioMedicine"},{"issue":"9","key":"3276_CR48","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1158\/0008-5472.CAN-12-3981","volume":"73","author":"J Xu","year":"2013","unstructured":"Xu J, Escamilla J, Mok S, David J, Priceman S, West B, Bollag G, McBride W, Wu L (2013) CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. Cancer Res 73(9):2782\u20132794. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3981","journal-title":"Cancer Res"},{"issue":"18","key":"3276_CR49","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1073\/pnas.0911378107","volume":"107","author":"GO Ahn","year":"2010","unstructured":"Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A, Brown JM (2010) Inhibition of Mac-1 (CD11b\/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci U S A 107(18):8363\u20138368","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3276_CR50","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.7150\/thno.49421","volume":"11","author":"Q Cao","year":"2021","unstructured":"Cao Q, Huang Q, Wang YA, Li C (2021) Abraxane-induced bone marrow CD11b(+) myeloid cell depletion in tumor-bearing mice is visualized by muPET-CT with (64)Cu-labeled anti-CD11b and prevented by anti-CSF-1. Theranostics 11(7):3527\u20133539","journal-title":"Theranostics"},{"issue":"10","key":"3276_CR51","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/14712598.2018.1523392","volume":"18","author":"P de Graaff","year":"2018","unstructured":"de Graaff P, Govers C, Wichers HJ, Debets R (2018) Consumption of beta-glucans to spice up T cell treatment of tumors: a review. Expert Opin Biol Ther 18(10):1023\u20131040. https:\/\/doi.org\/10.1080\/14712598.2018.1523392","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"3276_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124809","volume":"10","author":"K Kawata","year":"2015","unstructured":"Kawata K, Iwai A, Muramatsu D, Aoki S, Uchiyama H, Okabe M, Hayakawa S, Takaoka A, Miyazaki T (2015) Stimulation of macrophages with the beta-glucan produced by aureobasidium pullulans promotes the secretion of tumor necrosis factor-related apoptosis inducing ligand (TRAIL). PLoS ONE 10(4):e0124809. https:\/\/doi.org\/10.1371\/journal.pone.0124809","journal-title":"PLoS ONE"},{"key":"3276_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010242","author":"T Suzuki","year":"2021","unstructured":"Suzuki T, Kusano K, Kondo N, Nishikawa K, Kuge T, Ohno N (2021) Biological activity of high-purity \u03b2-1,3\u20131,6-Glucan derived from the black yeast aureobasidium pullulans: a literature review. Nutrients. https:\/\/doi.org\/10.3390\/nu13010242","journal-title":"Nutrients"},{"issue":"3","key":"3276_CR54","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4161\/cbt.8.3.7337","volume":"8","author":"M Driscoll","year":"2009","unstructured":"Driscoll M, Hansen R, Ding C, Cramer DE, Yan J (2009) Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy. Cancer Biol Ther 8(3):218\u2013225. https:\/\/doi.org\/10.4161\/cbt.8.3.7337","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"3276_CR55","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.4049\/jimmunol.1101303","volume":"188","author":"M Kornete","year":"2012","unstructured":"Kornete M, Sgouroudis E, Piccirillo CA (2012) ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol 188(3):1064\u20131074. https:\/\/doi.org\/10.4049\/jimmunol.1101303","journal-title":"J Immunol"},{"key":"3276_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12918-015-0202-y","volume":"9","author":"D Chen","year":"2015","unstructured":"Chen D, Liu X, Yang Y, Yang H, Lu P (2015) Systematic synergy modeling: understanding drug synergy from a systems biology perspective. BMC Syst Biol 9:56. https:\/\/doi.org\/10.1186\/s12918-015-0202-y","journal-title":"BMC Syst Biol"},{"key":"3276_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100110","volume":"3","author":"D Duarte","year":"2022","unstructured":"Duarte D, Vale N (2022) Evaluation of synergism in drug combinations and reference models for future orientations in oncology. Curr Res Pharmacol Drug Discov 3:100110. https:\/\/doi.org\/10.1016\/j.crphar.2022.100110","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"2","key":"3276_CR58","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70(2):440\u2013446. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1947","journal-title":"Cancer Res"},{"key":"3276_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fphar.2018.00031","volume":"9","author":"S Lederer","year":"2018","unstructured":"Lederer S, Dijkstra TMH, Heskes T (2018) Additive dose response models: explicit formulation and the loewe additivity consistency condition. Front Pharmacol 9:31. https:\/\/doi.org\/10.3389\/fphar.2018.00031","journal-title":"Front Pharmacol"},{"issue":"2","key":"3276_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/19466315.2018.1437071","volume":"10","author":"Q Liu","year":"2018","unstructured":"Liu Q, Yin X, Languino LR, Altieri DC (2018) Evaluation of drug combination effect using a Bliss independence dose-response surface model. Stat Biopharm Res 10(2):112\u2013122. https:\/\/doi.org\/10.1080\/19466315.2018.1437071","journal-title":"Stat Biopharm Res"},{"issue":"1","key":"3276_CR61","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s42003-021-02500-8","volume":"4","author":"AK Grosskopf","year":"2021","unstructured":"Grosskopf AK, Correa S, Baillet J, Maikawa CL, Gale EC, Brown RA, Appel EA (2021) Consistent tumorigenesis with self-assembled hydrogels enables high-powered murine cancer studies. Commun Biol 4(1):985. https:\/\/doi.org\/10.1038\/s42003-021-02500-8","journal-title":"Commun Biol"},{"issue":"6","key":"3276_CR62","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/nprot.2012.053","volume":"7","author":"R Fridman","year":"2012","unstructured":"Fridman R, Benton G, Aranoutova I, Kleinman HK, Bonfil RD (2012) Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection. Nat Protoc 7(6):1138\u20131144. https:\/\/doi.org\/10.1038\/nprot.2012.053","journal-title":"Nat Protoc"},{"issue":"1","key":"3276_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.30802\/AALAS-CM-18-000036","volume":"69","author":"N Fowlkes","year":"2019","unstructured":"Fowlkes N, Clemons K, Rider PJ, Subramanian R, Wakamatsu N, Langohr I, Kousoulas KG (2019) Factors affecting growth kinetics and spontaneous metastasis in the B16F10 syngeneic murine melanoma model. Comp Med 69(1):48\u201354","journal-title":"Comp Med"},{"issue":"2","key":"3276_CR64","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1158\/2326-6066.CIR-14-0118","volume":"3","author":"S Chen","year":"2015","unstructured":"Chen S, Lee LF, Fisher TS, Jessen B, Elliott M, Evering W, Logronio K, Tu GH, Tsaparikos K, Li X et al (2015) Combination of 4\u20131BB agonist and PD-1 antagonist promotes antitumor effector\/memory CD8 T cells in a poorly immunogenic tumor model. Cancer Immunol Res 3(2):149\u2013160. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0118","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"3276_CR65","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/cgt.2008.89","volume":"16","author":"N Grinshtein","year":"2009","unstructured":"Grinshtein N, Ventresca M, Margl R, Bernard D, Yang TC, Millar JB, Hummel J, Beermann F, Wan Y, Bramson JL (2009) High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome. Cancer Gene Ther 16(4):338\u2013350. https:\/\/doi.org\/10.1038\/cgt.2008.89","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"3276_CR66","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.1201209","volume":"190","author":"JR Baird","year":"2013","unstructured":"Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, Alexander MP, Sheen MR, Fox BA, Bzik DJ, Bosenberg M et al (2013) Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. J Immunol 190(1):469\u2013478. https:\/\/doi.org\/10.4049\/jimmunol.1201209","journal-title":"J Immunol"},{"issue":"1","key":"3276_CR67","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s40425-019-0811-x","volume":"7","author":"MJ Reilley","year":"2019","unstructured":"Reilley MJ, Morrow B, Ager CR, Liu A, Hong DS, Curran MA (2019) TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma. J Immunother Cancer 7(1):323. https:\/\/doi.org\/10.1186\/s40425-019-0811-x","journal-title":"J Immunother Cancer"},{"issue":"9","key":"3276_CR68","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.4049\/jimmunol.1402550","volume":"194","author":"AP Bally","year":"2015","unstructured":"Bally AP, Lu P, Tang Y, Austin JW, Scharer CD, Ahmed R, Boss JM (2015) NF-kappaB regulates PD-1 expression in macrophages. J Immunol 194(9):4545\u20134554. https:\/\/doi.org\/10.4049\/jimmunol.1402550","journal-title":"J Immunol"},{"issue":"2","key":"3276_CR69","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI67313","volume":"124","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu YX (2014) Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 124(2):687\u2013695. https:\/\/doi.org\/10.1172\/JCI67313","journal-title":"J Clin Invest"},{"issue":"8","key":"3276_CR70","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K et al (2002) Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8(8):793\u2013800. https:\/\/doi.org\/10.1038\/nm730","journal-title":"Nat Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-022-03276-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T01:28:47Z","timestamp":1677115727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-022-03276-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3276"],"URL":"https:\/\/doi.org\/10.1007\/s00262-022-03276-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"19 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KK is an employee of Aureo Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Mice were cared for in accordance with the National Research Institute for Child Health and Development (NCCHD) guidelines (A2017-005-C03) on laboratory animal welfare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}